Plant lectins are carbohydrate-binding proteins, which can interact with cell surfaces to initiate both inflammatory and antiinflammatory pathways, as well as immunomodulatory functions. Here, we extracted, purified and part-characterized the bioactivity of four seed lectins, Jacalin, Frutalin, DAL and PNA, before evaluating their potential for wound healing in cultured human skin fibroblasts. Only Frutalin stimulated fibroblast migration in vitro, prompting further studies which established its low cytotoxicity (unaffected fibroblast viability at ≤1 mg/mL) and interaction with TLR-4 receptors. The lectin also increased pERK expression, a marker of fibroblast proliferation, and stimulated IL-6 secretion. The in vivo potential of Frutalin for wound healing was then assessed in hybrid combination with the polysaccharide galactomannan, purified from Caesalpinia pulcherrima seeds, using both hydrogel formulations and membrane scaffolds (lyophilized hydrogel). Physicalchemical characterization of the hybrid showed that lectin-galactomannan interactions increased the pseudoplastic behaviour of solutions, reducing viscosity and increasing Frutalin's concentration. Furthermore, infrared spectroscopy revealed-OH band displacement (from 3350 to 3595 cm-1), likely caused by interaction of Frutalin with galactose residues present on galactomannan chains, while average membrane porosity was 100 μm, sufficient to ensure water vapor permeability. The healing activities of each hybrid material at three different Frutalin to galactomannan ratios were then tested in a surgical mouse model of cutaneous excisional wound repair. Accelerated angiogenesis and increased fibroblast and keratinocyte proliferation were observed with the optimal hybrid recovering the lesioned area after 11 days. Our findings indicate Frutalin as a biomolecule with potential for tissue repair, regeneration and chronic wound healing.